RE:RE:1st Quarter Results to be Released May 12th After Closejabez3 wrote: Any quesses Monty?
Procedure volumes might be a little dicey given the COVID-19 pandemic emerged in March. Q2 will obvioulsy be far worse.
I think the most important thing to look to in Q1 is the reimbursement rate trend. The company doesn't disclose their Revenue mix of contracted/non-contracted procedures and I have a feeling Average Revenue per Case is continuing to drift down as the company moves towards getting "in-network" with all the major insurers. I've always found it odd the company doesn't disclose their out-of-network volume. Like are the margins sky high because the company is capitalizing on surprise billing / out of network cases?
In any event, getting in-network will result in an average lower $/Case but this will ultimately give more certainty as to reimbursement rates, which is what the institutional players want. They don't want surprises from quarter-to-quarter. In this regard, the hiring of Mr. Griffin to the BOD can be viewed as a great addition to the CRH team.